subject: CHEBI:85083

object_name: inability to impregnate


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: male infertility

tested_intervention: unsure


subject: CHEBI:82977


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: PUBCHEM.COMPOUND:66811198


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Refractory Osteosarcoma


subject: CHEBI:4672

object_name: Osteosarcoma recurrent


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: MESH:C000632241

subject_name: caprylidene

object_name: Alzheimer disease type 1

tested_intervention: yes


subject: MESH:C000632241

object_name: Alzheimer disease


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: discoid lupus erythematosus


subject: CHEBI:58097

object_name: Restless legs


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:4856

subject_name: Esmolol

object_name: chronic rhinosinusitis


subject: CHEBI:17688

subject_name: Nicotine

object_name: Nicotine dependence, other tobacco product


subject: UMLS:C4727057

subject_name: Soluble Guanylate Cyclase Stimulator IW-1701

object_name: sickle cell disease


subject: CHEBI:25017

subject_name: leucine

object_name: sarcopenia


subject: CHEBI:25017

object_name: Atrophic


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Adhesive small bowel obstruction


subject: UNII:55E08EN074

object_name: melanoma


subject: UNII:F85N2YHE4E

subject_name: Omega-3-carboxylic acids

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:173763

subject_name: Thermophillin

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:173763

object_name: Recurrent Glioblastoma


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER


subject: CHEMBL.COMPOUND:CHEMBL55643


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:28694


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:29036


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: renal cell adenocarcinoma


subject: UMLS:C1744162

subject_name: RPL 554

object_name: COPD, severe early onset


subject: UMLS:C1744162

object_name: chronic obstructive pulmonary disease


subject: MESH:D010919

subject_name: Placebos


subject: MESH:D010919


subject: CHEBI:27470

subject_name: Folic acid

object_name: inflammatory bowel disease


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: fragile X syndrome


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:187888

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:187888

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: PUBCHEM.COMPOUND:74380454

subject_name: Volixibat

object_name: sclerosing cholangitis


subject: PUBCHEM.COMPOUND:74380454

object_name: primary sclerosing cholangitis


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: rheumatoid arthritis


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: lymphoblastic lymphoma


subject: UNII:D733ET3F9O

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:D733ET3F9O

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: PUBCHEM.COMPOUND:2269

object_name: Chronic lung disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: MESH:C478242

subject_name: vaxigrip

object_name: Immune Tolerance


subject: MESH:C478242

object_name: Drug Tolerance


subject: MESH:C478242

object_name: Immunization reaction


subject: MESH:C478242

object_name: Pregnancy Complications, Infectious


subject: MESH:C478242

object_name: Vaccine adverse reaction


subject: MESH:C478242

object_name: Infection in the elderly


subject: MESH:C478242

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C478242

object_name: obesity


subject: MESH:C478242

object_name: Obesity, CTCAE


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Pruritus, CTCAE


subject: CHEBI:184693

object_name: Pruritus


subject: UNII:TC549UFL8P

object_name: Hirschsprung disease


subject: UNII:TC549UFL8P

object_name: Hirschsprung disease, susceptibility to, 1


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: plasma cell leukemia


subject: UMLS:C1709429


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:45716

subject_name: Vorinostat

object_name: sickle cell disease


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: brain cancer


subject: CHEBI:63584

object_name: brain neoplasm


subject: PUBCHEM.COMPOUND:54681072

subject_name: Omadacycline

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:54681072

object_name: Skin structures and soft tissue infections


subject: UNII:090IP5RV8F


subject: UNII:090IP5RV8F


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Carcinoma breast stage IV


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: metastatic colorectal cancer


subject: CHEBI:61606

object_name: type 2 diabetes mellitus


subject: CHEBI:61606

object_name: Insulin resistance


subject: CHEBI:61606

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:61606

object_name: obesity


subject: CHEBI:61606

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: PUBCHEM.COMPOUND:53477767


subject: PUBCHEM.COMPOUND:53477767


subject: PUBCHEM.COMPOUND:53477767


subject: PUBCHEM.COMPOUND:53477767


subject: UMLS:C0594139

subject_name: Alphanate

object_name: hemophilia A


subject: CHEBI:7772

subject_name: omeprazole

object_name: achlorhydria


subject: CHEBI:7772

object_name: osteoporosis


subject: CHEBI:7772

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:7772

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:7772

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:7772

object_name: Pelvis fracture


subject: CHEBI:7772

object_name: Hip Fracture, CTCAE


subject: CHEBI:7772

object_name: hip fracture


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:3515

subject_name: Cefuroxime

object_name: Uterine prolapse without mention of vaginal wall prolapse


subject: CHEBI:3515

object_name: Uterine prolapse


subject: CHEBI:3515

object_name: Rectocele


subject: CHEBI:3515

object_name: Hernia


subject: CHEBI:3515

object_name: Cystocele


subject: CHEBI:80270

object_name: hyperglycemia


subject: CHEBI:80270

object_name: Hyperglycemia, CTCAE


subject: CHEBI:80270

object_name: Glucose in blood specimen above reference range


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177

object_name: maturity-onset diabetes of the young type 1


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: PR:000008039


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: RENAL CELL CARCINOMA, CLEAR CELL, SOMATIC


subject: MESH:D019433

subject_name: Chickenpox Vaccine

object_name: HIV infection


subject: UMLS:C4552074

object_name: myelofibrosis


subject: UMLS:C3255751

subject_name: chitosan oligosaccharide

object_name: Prediabetes


subject: UMLS:C3255751

object_name: glucose intolerance


subject: UMLS:C3255751

object_name: Impaired glucose tolerance


subject: UMLS:C3255751

object_name: Impaired fasting glucose


subject: UMLS:C3255751

object_name: Normal Appearance of Extremities


subject: UMLS:C3255751

object_name: TP53 Gene Mutation Negative


subject: UMLS:C3255751

object_name: normal Device Alert Level


subject: UMLS:C3255751

object_name: Normal Chest Appearance


subject: UMLS:C3255751

object_name: Normal Point of Maximum Impulse


subject: UMLS:C3255751

object_name: Normal Abdomen on Palpation


subject: UMLS:C3255751

object_name: Serum CA 19-9 Normal


subject: UMLS:C3255751

object_name: Normal assessment finding


subject: UMLS:C3255751

object_name: Normal Capillary Refill Time


subject: UMLS:C3255751

object_name: Normal Observation Interpretation


subject: UMLS:C3255751

object_name: Normal Abdomen on Visual Inspection


subject: UMLS:C3255751

object_name: Normal Precordial Palpation Finding


subject: UMLS:C3255751

object_name: Serum CEA Level Normal


subject: UMLS:C3255751

object_name: Normal Skin


subject: UMLS:C3255751

object_name: Normal Male External Genitalia


subject: UMLS:C3255751

object_name: Cytogenetic Abnormalities Not Detected


subject: UMLS:C3255751

object_name: Normal Immune Presence


subject: MESH:C000614667

object_name: Prediabetes


subject: MESH:C000614667

object_name: glucose intolerance


subject: MESH:C000614667

object_name: Impaired glucose tolerance


subject: MESH:C000614667

object_name: Impaired fasting glucose


subject: MESH:C000614667

object_name: Normal Appearance of Extremities


subject: MESH:C000614667

object_name: TP53 Gene Mutation Negative


subject: MESH:C000614667

object_name: normal Device Alert Level


subject: MESH:C000614667

object_name: Normal Chest Appearance


subject: MESH:C000614667

object_name: Normal Point of Maximum Impulse


subject: MESH:C000614667

object_name: Normal Abdomen on Palpation


subject: MESH:C000614667

object_name: Serum CA 19-9 Normal


subject: MESH:C000614667

object_name: Normal assessment finding


subject: MESH:C000614667

object_name: Normal Capillary Refill Time


subject: MESH:C000614667

object_name: Normal Observation Interpretation


subject: MESH:C000614667

object_name: Normal Abdomen on Visual Inspection


subject: MESH:C000614667

object_name: Normal Precordial Palpation Finding


subject: MESH:C000614667

object_name: Serum CEA Level Normal


subject: MESH:C000614667

object_name: Normal Skin


subject: MESH:C000614667

object_name: Normal Male External Genitalia


subject: MESH:C000614667

object_name: Cytogenetic Abnormalities Not Detected


subject: MESH:C000614667

object_name: Normal Immune Presence


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: neoplasm of esophagus


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: UMLS:C4765216

subject_name: YSPSL

object_name: kidney disorder


subject: UMLS:C4765363

subject_name: rPSGL-Ig


subject: PUBCHEM.COMPOUND:19609831

subject_name: Rebimastat

object_name: Stage IV Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:19609831

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:19609831

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:19609831

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:19609831

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:19609831

object_name: prostate adenocarcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: UNII:6XC1PAD3KF


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:41948

subject_name: Eflornithine

object_name: prostate carcinoma


subject: CHEBI:41948

object_name: prostate cancer


subject: CHEBI:45783

subject_name: Imatinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:45783

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:45783

object_name: stage IIIB melanoma


subject: CHEBI:45783

object_name: stage IIIC melanoma


subject: CHEBI:45783

object_name: stage IIIA melanoma


subject: CHEBI:45783

object_name: Melanoma recurrent


subject: CHEBI:45783

object_name: acral lentiginous melanoma


subject: UMLS:C4053652

subject_name: Anti-human Cytomegalovirus Monoclonal Antibody Combination CSJ-148

object_name: cytomegalovirus infection


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Colorectal cancer stage IV


subject: CHEBI:90205

subject_name: Plitidepsin


subject: CHEBI:90205


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: PUBCHEM.COMPOUND:73313844


subject: PUBCHEM.COMPOUND:57503717

subject_name: APLIDIN


subject: PUBCHEM.COMPOUND:57503717


subject: UMLS:C0388638

subject_name: plitidepsin


subject: UMLS:C0388638


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Breast neoplasm female


subject: CHEBI:31485

subject_name: Difluprednate

object_name: corneal edema


subject: CHEBI:31485

object_name: Bilateral cataracts (disorder)


subject: CHEBI:31485

object_name: cataract


subject: CHEBI:31485

object_name: Visual acuity reduced transiently


subject: CHEBI:31485

object_name: Retinal structural change, deposit and degeneration


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Depressed mood


subject: CHEBI:84094

object_name: Cancer patients and suicide and depression


subject: CHEBI:84094

object_name: Depressed - symptom


subject: CHEBI:84094

object_name: Depression, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: neuroendocrine carcinoma


subject: UNII:Y68179SY2L


subject: UMLS:C0972319

subject_name: BIIL 284

object_name: cystic fibrosis


subject: CHEBI:71952

subject_name: Dactolisib

object_name: Carcinoma breast stage IV


subject: CHEBI:71952

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:71952

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: CHEBI:58097

object_name: osteoarthritis


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C1832001

object_name: glioblastoma


subject: UMLS:C1832001

object_name: Brain Stem Glioblastoma


subject: UMLS:C1832001

object_name: glioma susceptibility 1


subject: UMLS:C0731794

subject_name: Icodextrin peritoneal dialysis solution

object_name: end stage renal failure


subject: UMLS:C0731794

object_name: Chronic uremia


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: Electrocardiographic Finding


subject: UNII:8GZG754X6M

object_name: electrocardiography


subject: UNII:8GZG754X6M

object_name: Abnormal EKG


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C0677800


subject: UMLS:C5706487

subject_name: MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000

object_name: trabecular adenocarcinoma


subject: UMLS:C5706487

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:18248

subject_name: Iron

object_name: Iron deficiency anemia of pregnancy


subject: CHEBI:18248

object_name: Malabsorption - iron


subject: DRUGBANK:DB17439

object_name: Metastatic Cutaneous Melanoma


subject: DRUGBANK:DB17439

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: DRUGBANK:DB17439

object_name: metastatic melanoma


subject: DRUGBANK:DB17439

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: DRUGBANK:DB17439

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: respiratory failure


subject: PUBCHEM.COMPOUND:74030550

object_name: bronchopulmonary dysplasia


subject: PUBCHEM.COMPOUND:74030550

object_name: Respiratory insufficiency


subject: MESH:D056692

subject_name: Prebiotics

object_name: infectious disease


subject: CHEBI:3011

subject_name: Benazepril

object_name: dilated cardiomyopathy


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:9927

subject_name: Valsartan


subject: UMLS:C3490133

object_name: colorectal cancer


subject: UMLS:C3490133

object_name: colorectal carcinoma


subject: UMLS:C3490133

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Cooley's anemia


subject: UMLS:C3641690


subject: UNII:8BR2SOL3L1

object_name: metastatic prostate carcinoma


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Vaccine response impaired


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: CHEBI:40279

subject_name: Allopurinol

object_name: resistant hypertension


subject: CHEBI:40279

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:40279

object_name: diastolic heart failure


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Age-related cognitive decline


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Neck Carcinoma


subject: CHEBI:35176

object_name: head and neck neoplasm


subject: CHEBI:35176

object_name: head and neck cancer


subject: CHEBI:35176

object_name: Radiation Sickness


subject: CHEBI:35176

object_name: Oral Complication


subject: CHEBI:35176

object_name: Dysgeusia, CTCAE


subject: CHEBI:35176

object_name: Parageusia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: hypopituitarism


subject: CHEBI:17650

object_name: Hypopituitarism, CTCAE


subject: CHEBI:17650

object_name: Insulin Sensitivity


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Neuroendocrine Tumor G3


subject: CHEBI:17688

subject_name: Nicotine


subject: CHEBI:17688

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: malignant soft tissue neoplasm


subject: CHEBI:15698

object_name: sarcoma


subject: CHEBI:15698

object_name: nephroblastoma


subject: CHEBI:15698

object_name: Childhood Neuroblastoma


subject: CHEBI:15698

object_name: neuroblastoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: PUBCHEM.COMPOUND:3962

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: prostate cancer


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: UMLS:C5238479

subject_name: EZH2 Inhibitor CPI-0209

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: diabetic neuropathy


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Delayed cerebral ischaemia


subject: PUBCHEM.COMPOUND:54675783

object_name: Aneurysm, Ruptured


subject: PUBCHEM.COMPOUND:54675783

object_name: Blood brain barrier defect


subject: PUBCHEM.COMPOUND:54675783

object_name: intracranial vasospasm


subject: UMLS:C4687975

subject_name: cEt KRAS Antisense Oligonucleotide AZD4785

object_name: non-small cell lung carcinoma


subject: UMLS:C0733796

subject_name: Gastrografin

object_name: Small bowel obstruction


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: Dysfunction of urinary bladder


subject: CHEBI:51141

object_name: multiple sclerosis


subject: UNII:6ZJ8V3Q0H1

object_name: lymphoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: breast neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: lymphoid interstitial pneumonia


subject: CHEBI:6801

object_name: benign neoplasm of lip


subject: CHEBI:6801

object_name: Neoplasm of uncertain or unknown behavior of larynx


subject: CHEBI:6801

object_name: laryngeal disorder


subject: CHEBI:6801

object_name: larynx carcinoma in situ


subject: CHEBI:6801

object_name: benign laryngeal neoplasm


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Therapeutic Abortion with Complications


subject: CHEBI:63610

object_name: Therapeutic Abortion Finding


subject: CHEBI:63610

object_name: Therapeutic abortion


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: Intestinal Failure


subject: UMLS:C1098514


subject: UMLS:C2826384

object_name: ovarian cancer


subject: UMLS:C2826384

object_name: ovarian neoplasm


subject: UMLS:C2826384

object_name: ovarian carcinoma


subject: UMLS:C2826384

object_name: ovarian disease


subject: UMLS:C2826384

object_name: carcinoma


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: Adult Meningioma


subject: UMLS:C3898831

object_name: benign meningioma


subject: UMLS:C3898831

object_name: familial meningioma


subject: UMLS:C3898831

object_name: pediatric meningioma


subject: UMLS:C3898831

object_name: meningioma


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Gastrointestinal hemorrhage


subject: CHEBI:33569

object_name: digestive system disorder


subject: CHEBI:33569

object_name: gastrointestinal disease


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:5441

subject_name: Glyburide

object_name: multiple sclerosis


subject: CHEBI:5441

object_name: neuralgia


subject: CHEBI:5441

object_name: Neuropathic pain


subject: UNII:2N71QUE3NL

object_name: Solid Neoplasm


subject: UMLS:C3640817

subject_name: Ipafricept


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: amyotrophic lateral sclerosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: cholangiocarcinoma


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:8871

subject_name: Risperidone

object_name: History of - psychiatric disorder


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Gastroesophageal junction cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C4305964

object_name: psoriasis


subject: UMLS:C2095775

subject_name: ampicillins

object_name: Premature birth


subject: UMLS:C2095775

object_name: perinatal necrotizing enterocolitis


subject: UMLS:C2095775

object_name: necrotizing enterocolitis


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:28971


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:42944

subject_name: Galantamine

object_name: Chronic schizophrenia


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: female stress incontinence


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation


subject: UMLS:C1550506

subject_name: product - ParticipationType


subject: UNII:N65WC8PXDD

subject_name: Xevinapant

object_name: head and neck squamous cell carcinoma


subject: UNII:N65WC8PXDD

object_name: laryngeal squamous cell carcinoma


subject: UNII:N65WC8PXDD

object_name: oral cavity squamous cell carcinoma


subject: UNII:N65WC8PXDD

object_name: oropharynx squamous cell carcinoma


subject: UNII:N65WC8PXDD

object_name: hypopharynx squamous cell carcinoma


subject: UNII:N65WC8PXDD

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:N65WC8PXDD

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: CHEBI:197401


subject: UMLS:C5706410

subject_name: KRAS G12C Inhibitor BPI-421286

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5706410

object_name: Embolism, Tumor


subject: UMLS:C5706410

object_name: Neoplasm Metastasis


subject: UMLS:C5706410

object_name: cancer


subject: UMLS:C5706410

object_name: nervous system cancer


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: toxic epidermal necrolysis


subject: UNII:QMS40680K6

object_name: Toxic Epidermal Necrolysis, CTCAE


subject: UNII:QMS40680K6

object_name: Stevens-Johnson syndrome


subject: UNII:QMS40680K6

object_name: Stevens-Johnson Syndrome, CTCAE


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection

object_name: pemphigus


subject: UMLS:C5203254

object_name: skin disorder


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: acute myocardial infarction


subject: CHEBI:85078

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: Graft Rejection


subject: UMLS:C2093603

subject_name: Rabbit


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: rheumatic heart disease


subject: CHEBI:601027

subject_name: Aliskiren

object_name: kidney disorder


subject: CHEBI:601027

object_name: impaired renal function disease


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: plasma cell myeloma


subject: CHEBI:3814

subject_name: Colestipol

object_name: erythropoietic protoporphyria


subject: CHEBI:3814

object_name: protoporphyria, erythropoietic, 1


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: multiple sclerosis


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: Plasma cell myeloma refractory


subject: UNII:DB1041CXDG

object_name: Plasma cell myeloma recurrent


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: brain neoplasm


subject: CHEBI:4696

object_name: metastatic neoplasm


subject: CHEBI:4696

object_name: Embolism, Tumor


subject: CHEBI:4696

object_name: Neoplasm Metastasis


subject: CHEBI:4696

object_name: Metastatic Lesion


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:95165

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:95165

object_name: Bladder cancer recurrent


subject: CHEBI:95165

object_name: Breast cancer recurrent


subject: CHEBI:95165

object_name: Melanoma recurrent


subject: CHEBI:95165

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:95165

object_name: Bladder cancer stage IV


subject: CHEBI:95165

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:95165

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:95165

object_name: Carcinoma breast stage IV


subject: CHEBI:95165

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:95165

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:95165

object_name: male breast carcinoma


subject: CHEBI:95165

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:95165

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:95165

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:K82DG47I0G

subject_name: PEXASTIMOGENE DEVACIREPVEC

object_name: liver carcinoma


subject: UMLS:C4722744

subject_name: Pexa-vec


subject: UMLS:C5706483

subject_name: Anti-MICA/MICB Monoclonal Antibody CLN-619

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706483

object_name: non-small cell lung carcinoma


subject: UMLS:C5978507

subject_name: datopotamab deruxtecan-dlnk


subject: UMLS:C5978507


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:151315

subject_name: Heparin

object_name: interstitial cystitis


subject: CHEBI:151315

object_name: Painful Bladder Syndrome


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Drug Interactions


subject: CHEBI:6950

object_name: Adverse drug interaction


subject: CHEBI:6950

object_name: cardiovascular disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:73604

object_name: Adult Solid Neoplasm


subject: CHEBI:367163

subject_name: Darunavir

object_name: Acute HIV infection


subject: CHEBI:63589

subject_name: Etravirine


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:16899

subject_name: Mannitol

object_name: Constipation


subject: CHEBI:16899

object_name: Constipation, CTCAE


subject: UNII:NA2ZOL5UGM

object_name: inborn mitochondrial metabolism disorder


subject: UNII:NA2ZOL5UGM

object_name: mitochondrial disease


subject: UNII:NA2ZOL5UGM

object_name: inborn mitochondrial myopathy


subject: UNII:NA2ZOL5UGM

object_name: Mitochondrial Respiratory Chain Deficiencies


subject: UNII:NA2ZOL5UGM

object_name: MELAS syndrome


subject: UMLS:C2930721

object_name: copd bronchitis


subject: UNII:E3YZ3E0CZ6

object_name: HIV infection


subject: CHEBI:183668

subject_name: Lysine Butyrate

object_name: digestive system disorder


subject: UMLS:C0615214

subject_name: lysine butyrate


subject: CHEBI:177770

subject_name: Ganetespib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:177770

object_name: acute lymphoblastic leukemia


subject: CHEBI:177770

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:6427

subject_name: Leuprolide

object_name: Androgen excess


subject: CHEBI:6427

object_name: Increased circulating androgen concentration


subject: UMLS:C5783443

subject_name: KRAS G12C Inhibitor IBI351


subject: UMLS:C5783443

object_name: metastatic colorectal cancer


subject: CHEBI:10033

subject_name: Warfarin

object_name: Left Ventricular Thrombus Related to COVID-19


subject: CHEBI:10033

object_name: Left ventricular thrombus


subject: GTOPDB:1160

subject_name: hCG

object_name: female infertility


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: aphthous stomatitis


subject: PUBCHEM.COMPOUND:6096882

object_name: Oral ulcer


subject: PUBCHEM.COMPOUND:6096882

object_name: Periadenitis Mucosa Necrotica Recurrens


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: bacterial infectious disease


subject: CHEBI:60648

object_name: Mycoses


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:231594

subject_name: Norgestrel

object_name: endometrial cancer


subject: CHEBI:231594

object_name: uterine corpus cancer


subject: CHEBI:231594

object_name: endometrial carcinoma


subject: CHEBI:231594

object_name: Atypical hyperplasia


subject: CHEBI:194186

subject_name: Tirzepatide


subject: CHEBI:194186


subject: CHEBI:194186


subject: CHEBI:194186


subject: UMLS:C5672423

subject_name: Mounjaro


subject: UMLS:C5672423


subject: UMLS:C5672423


subject: UMLS:C5672423


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: Brain Stem Glioblastoma


subject: CHEBI:63635

object_name: glioma susceptibility 1


subject: CHEBI:44915

subject_name: Propofol

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:44915

object_name: obesity due to leptin receptor gene deficiency


subject: PUBCHEM.COMPOUND:64987

object_name: Renal function disorder


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:140487

object_name: heart failure


subject: CHEBI:140487

object_name: Heart Failure, CTCAE


subject: CHEBI:140487

object_name: dilated cardiomyopathy


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Surgical procedure finding


subject: CHEBI:35475

object_name: pituitary gland adenoma


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UNII:F84YQX13FV

object_name: type 2 diabetes mellitus


subject: CHEBI:9241

subject_name: Spironolactone

object_name: cancer


subject: CHEBI:9241

object_name: neoplasm


subject: CHEBI:60648

object_name: Pancreas carcinoma resectable


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C4053581

object_name: gastroesophageal cancer


subject: UMLS:C4053581

object_name: carcinoma of esophagus


subject: UMLS:C4053581

object_name: esophageal cancer


subject: UMLS:C4053581

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4053581

object_name: neoplasm of esophagus


subject: UMLS:C5709303

object_name: facioscapulohumeral muscular dystrophy 1


subject: UMLS:C5709303

object_name: limb-girdle muscular dystrophy


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Postoperative Complications


subject: CHEBI:22652

object_name: Ventilator-Induced Lung Injury


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: osteoarthritis


subject: CHEBI:62880

subject_name: Veliparib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:62880

object_name: lung large cell carcinoma


subject: CHEBI:62880

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:62880

object_name: neuroendocrine carcinoma


subject: CHEBI:62880

object_name: small cell carcinoma


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: Extrapulmonary Small Cell Carcinoma


subject: GTOPDB:13396

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C2830128

object_name: non-small cell lung carcinoma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: lung cancer


subject: UNII:6XC1PAD3KF

object_name: lung neoplasm


subject: UNII:6XC1PAD3KF

object_name: lung carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:73508

subject_name: Glu-Pro


subject: CHEBI:73508


subject: CHEBI:73508


subject: PR:000006295

subject_name: acyl-CoA-binding protein


subject: PR:000006295


subject: PR:000006295


subject: PR:000008736

subject_name: BLOC-3 complex member HPS1


subject: PR:000008736


subject: PR:000008736


subject: CHEBI:73662

subject_name: Thr-Pro


subject: CHEBI:73662


subject: CHEBI:73662


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000029585


subject: PR:000029585


subject: PR:000009721


subject: PR:000009721


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: PR:000016875


subject: PR:000016875


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UMLS:C5444129


subject: UMLS:C5444129


subject: UMLS:C1328710

subject_name: SDX 105

object_name: non-Hodgkin lymphoma


subject: CHEBI:42588

subject_name: Fenretinide

object_name: High-Risk Cancer


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:73611

subject_name: Met-Gly

object_name: glioblastoma


subject: CHEBI:73611

object_name: Brain Stem Glioblastoma


subject: CHEBI:73611

object_name: glioma susceptibility 1


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:50853

subject_name: quantum dot


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:135078

subject_name: Cicletanine

object_name: type 2 diabetes mellitus


subject: CHEBI:135078

object_name: Diabetes


subject: CHEBI:135078

object_name: diabetes mellitus


subject: CHEBI:135078

object_name: hypertension


subject: CHEBI:135078

object_name: Hyponatremia


subject: CHEBI:135078

object_name: Hyponatremia, CTCAE


subject: CHEBI:135078

object_name: hypokalemia


subject: CHEBI:135078

object_name: Hypokalemia, CTCAE


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Heart failure with normal ejection fraction


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C3827082

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:6XG22YQM2Z

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4331912

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C4329594

subject_name: CEA-MUC-1-TRICOM Vaccine CV301

object_name: prostate carcinoma


subject: UMLS:C4329594

object_name: prostate cancer


subject: CHEBI:71952

subject_name: Dactolisib

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2347425


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:31348

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:31348

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:31348

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:31348

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:31348

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:31348

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:31348

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:31348

object_name: primary peritoneal carcinoma


subject: CHEBI:31348

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:31348

object_name: peritoneal carcinoma


subject: CHEBI:31348

object_name: Unresectable Melanoma


subject: CHEBI:31348

object_name: metastatic melanoma


subject: CHEBI:31348

object_name: malignant epithelial tumor of ovary


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:31355

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:31355

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:31355

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:31355

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:31355

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:31355


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:4026

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:4026

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:64816

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:64816

object_name: primary peritoneal carcinoma


subject: CHEBI:64816

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:64816

object_name: peritoneal carcinoma


subject: CHEBI:64816

object_name: Unresectable Melanoma


subject: CHEBI:64816

object_name: metastatic melanoma


subject: CHEBI:64816

object_name: ovarian cancer


subject: CHEBI:64816

object_name: ovarian carcinoma


subject: CHEBI:64816

object_name: malignant epithelial tumor of ovary


subject: CHEBI:91872

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:91872

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:91872

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:91872

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:91872

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:91872

object_name: primary peritoneal carcinoma


subject: CHEBI:91872

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:91872

object_name: peritoneal carcinoma


subject: CHEBI:91872

object_name: Unresectable Melanoma


subject: CHEBI:91872

object_name: metastatic melanoma


subject: CHEBI:91872

object_name: ovarian cancer


subject: CHEBI:91872

object_name: ovarian carcinoma


subject: CHEBI:91872

object_name: malignant epithelial tumor of ovary


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:28748

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:28748

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:28748

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:28748

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:28748

object_name: Unresectable Melanoma


subject: CHEBI:28748

object_name: metastatic melanoma


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:231005

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:231005

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:231005

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:231005

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:231005

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:231005

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:231005

object_name: primary peritoneal carcinoma


subject: CHEBI:231005

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:231005

object_name: peritoneal carcinoma


subject: CHEBI:231005

object_name: Unresectable Melanoma


subject: CHEBI:231005

object_name: metastatic melanoma


subject: CHEBI:231005

object_name: ovarian cancer


subject: CHEBI:231005

object_name: ovarian carcinoma


subject: CHEBI:231005

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63587

subject_name: Eribulin

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:63587

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:63587

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:63587

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:63587

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:63587

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:63587

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:63587

object_name: primary peritoneal carcinoma


subject: CHEBI:63587

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:63587

object_name: peritoneal carcinoma


subject: CHEBI:63587

object_name: Unresectable Melanoma


subject: CHEBI:63587

object_name: metastatic melanoma


subject: CHEBI:63587

object_name: ovarian cancer


subject: CHEBI:63587

object_name: ovarian carcinoma


subject: CHEBI:63587

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIC Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: papillary serous cystadenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: peritoneal carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:14907381

object_name: metastatic melanoma


subject: CHEBI:46345

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:46345

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:46345

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:46345

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:46345

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:46345

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:46345

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:46345

object_name: peritoneal carcinoma


subject: CHEBI:46345

object_name: Unresectable Melanoma


subject: CHEBI:46345

object_name: metastatic melanoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:231679

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679

object_name: fallopian tube carcinoma


subject: CHEBI:231679

object_name: ovarian cancer


subject: CHEBI:231679

object_name: ovarian carcinoma


subject: CHEBI:231679

object_name: malignant epithelial tumor of ovary


subject: CHEBI:90881

subject_name: Camptosar

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:90881

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:90881


subject: CHEBI:90881

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:90881

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:90881

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:90881

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:90881

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:90881

object_name: primary peritoneal carcinoma


subject: CHEBI:90881

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:90881

object_name: peritoneal carcinoma


subject: CHEBI:90881

object_name: fallopian tube carcinoma


subject: CHEBI:90881

object_name: Unresectable Melanoma


subject: CHEBI:90881

object_name: metastatic melanoma


subject: CHEBI:90881

object_name: ovarian cancer


subject: CHEBI:90881

object_name: ovarian carcinoma


subject: CHEBI:90881

object_name: malignant epithelial tumor of ovary


subject: CHEBI:8988

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:8988

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:8988

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:8988

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:8988

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:8988

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:8988

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:8988

object_name: Unresectable Melanoma


subject: CHEBI:8988

object_name: metastatic melanoma


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:80630

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:80630

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:80630

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:80630

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:80630

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:80630

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:80630

object_name: Unresectable Melanoma


subject: CHEBI:80630

object_name: metastatic melanoma


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:15640

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:15640

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:15640

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:15640

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:15640

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:15640

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:15640

object_name: peritoneal carcinoma


subject: CHEBI:15640

object_name: Unresectable Melanoma


subject: CHEBI:15640

object_name: metastatic melanoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:83766

subject_name: Olaparib

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:83766

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:83766

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:83766

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:83766

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:83766

object_name: Unresectable Melanoma


subject: CHEBI:83766

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage III Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Unresectable Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: papillary serous cystadenocarcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: peritoneal carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Unresectable Melanoma


subject: PUBCHEM.COMPOUND:43805

object_name: metastatic melanoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: UMLS:C1314429

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C1314429

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C1314429

object_name: Unresectable Renal Cell Carcinoma


subject: UMLS:C1314429

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C1314429

object_name: peritoneal carcinoma


subject: UMLS:C1314429

object_name: Unresectable Melanoma


subject: UMLS:C1314429

object_name: metastatic melanoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:45863


subject: CHEBI:45863

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:45863

object_name: Metastatic Renal Cell Cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Unresectable Renal Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: papillary serous cystadenocarcinoma


subject: UNII:DPT0O3T46P

object_name: peritoneal carcinoma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:95021

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:95021

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:95021


subject: CHEBI:95021

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:95021


subject: CHEBI:95021

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:95021


subject: CHEBI:95021

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:95021

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:95021

object_name: triple-negative breast carcinoma


subject: CHEBI:95021

object_name: fallopian tube carcinoma


subject: CHEBI:95021

object_name: Unresectable Melanoma


subject: CHEBI:95021

object_name: metastatic melanoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63724


subject: CHEBI:63724

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:63724


subject: CHEBI:63724

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:63724

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:63724

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:63724

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:63724

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63724


subject: CHEBI:63724

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:229764

subject_name: Selinexor

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:229764

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:229764

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:229764

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:229764

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:229764

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:229764

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:229764

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:229764

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:229764

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:229764

object_name: triple-negative breast carcinoma


subject: CHEBI:229764

object_name: primary peritoneal carcinoma


subject: CHEBI:229764

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:229764

object_name: peritoneal carcinoma


subject: CHEBI:229764

object_name: fallopian tube carcinoma


subject: CHEBI:229764

object_name: Unresectable Melanoma


subject: CHEBI:229764

object_name: metastatic melanoma


subject: CHEBI:229764

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63632

subject_name: Topotecan

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:63632

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:63632

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:63632

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:63632

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:63632

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:63632

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:63632

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:63632

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:63632

object_name: triple-negative breast carcinoma


subject: CHEBI:63632

object_name: Unresectable Melanoma


subject: CHEBI:63632

object_name: metastatic melanoma


subject: UMLS:C5544560

object_name: EXCESS LMW-DNA


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: Immunoglobulin G4-Related Disease


subject: UNII:6315412YVF

subject_name: Delafloxacin

object_name: Surgical Wound Infection


subject: UMLS:C5963434

subject_name: Gallium Ga 68 NNS309

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5963434


subject: UMLS:C5963434

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5963434

object_name: non-small cell lung carcinoma


subject: UMLS:C5963434

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5963434

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5963434

object_name: sarcoma


subject: UMLS:C5963434

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5963434

object_name: soft tissue sarcoma


subject: UMLS:C5963434

object_name: colorectal cancer


subject: UMLS:C5963434

object_name: colorectal carcinoma


subject: UMLS:C5963434

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:131854

subject_name: Fotemustine

object_name: melanoma


subject: CHEBI:3757

subject_name: Clonidine

object_name: Hypoxic-Ischemic Encephalopathy


subject: PUBCHEM.COMPOUND:65404

subject_name: fanasil, pyrimethamine drug combination

object_name: Pregnant


subject: PUBCHEM.COMPOUND:65404

object_name: Malaria, antepartum


subject: CHEBI:50659

subject_name: Dronedarone

object_name: paroxysmal atrial fibrillation


subject: CHEBI:50659

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:5281767

object_name: glucose intolerance


subject: PUBCHEM.COMPOUND:5281767

object_name: Abdominal obesity


subject: UNII:79O7855J4G

subject_name: Sepetaprost

object_name: ocular hypertension


subject: DRUGBANK:DB05579

object_name: diabetic polyneuropathy


subject: DRUGBANK:DB05579

object_name: type 1 diabetes mellitus 1


subject: DRUGBANK:DB05579

object_name: type 1 diabetes mellitus


subject: DRUGBANK:DB05579

object_name: type 2 diabetes mellitus


subject: CHEBI:15414

subject_name: Adomet

object_name: Depressed mood


subject: CHEBI:15414

object_name: Cancer patients and suicide and depression


subject: CHEBI:15414

object_name: Depressed - symptom


subject: CHEBI:15414

object_name: Depression, CTCAE


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:67040


subject: CHEBI:67040


subject: CHEBI:67040


subject: CHEBI:71204

subject_name: bepotastine

object_name: eye allergy


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Musculoskeletal Pain


subject: GTOPDB:12990

subject_name: sintilimab

object_name: malignant pleural mesothelioma


subject: GTOPDB:12990

object_name: malignant mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: UNII:GKF8S4C432


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: anaplastic astrocytoma


subject: UMLS:C0376659

object_name: glioblastoma


subject: UMLS:C0376659

object_name: Brain Stem Glioblastoma


subject: UMLS:C0376659

object_name: glioma susceptibility 1


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: glioma


subject: CHEBI:50847

object_name: malignant glioma


subject: CHEBI:50847


subject: CHEBI:50847


subject: CHEBI:50847


subject: CHEBI:50847


subject: PUBCHEM.COMPOUND:9884233

subject_name: ALBUTEROL SULFATE

object_name: asthma


subject: CHEBI:78825

subject_name: Avutometinib

object_name: Stomach cancer


subject: CHEBI:78825

object_name: gastric cancer


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: female infertility


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: prostate adenocarcinoma


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: chronic graft versus host disease


subject: CHEBI:34385

object_name: spinal cord injury


subject: CHEBI:100246

subject_name: Norfloxacin

object_name: Hermansky-Pudlak syndrome


subject: CHEBI:100246

object_name: hepatopulmonary syndrome


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: pediatric osteosarcoma


subject: UMLS:C5238233

object_name: Osteosarcoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: toothache


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:601027

subject_name: Aliskiren

object_name: congestive heart failure


subject: CHEBI:36080

subject_name: protein

object_name: colorectal cancer


subject: CHEBI:36080

object_name: colorectal carcinoma


subject: CHEBI:36080

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0033684

subject_name: Proteins


subject: UMLS:C0033684


subject: UMLS:C0033684


subject: PR:000000001


subject: PR:000000001


subject: PR:000000001


subject: CHEBI:18059

subject_name: lipid


subject: CHEBI:18059


subject: CHEBI:18059


subject: MESH:D008055

subject_name: Lipids


subject: MESH:D008055


subject: MESH:D008055


subject: CHEBI:75929

object_name: autism


subject: CHEBI:40009

subject_name: Cycloserine


subject: UMLS:C1097066

object_name: benign prostatic hyperplasia


subject: UMLS:C5241873

subject_name: peanut protein

object_name: peanut allergy


subject: CHEBI:42944

subject_name: Galantamine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:42944


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: carcinoma


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: sarcopenia


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally Advanced Malignant Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: carcinoid tumor


subject: CHEMBL.COMPOUND:CHEMBL1743003

subject_name: CONATUMUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: Disseminated Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL1743003


subject: CHEMBL.COMPOUND:CHEMBL1743003


subject: CHEMBL.COMPOUND:CHEMBL1743003


subject: CHEMBL.COMPOUND:CHEMBL1743003


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743003


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: neuroendocrine neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743003

object_name: sarcoma


subject: UMLS:C2346822

subject_name: conatumumab


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822

object_name: colorectal cancer


subject: UMLS:C2346822

object_name: colorectal carcinoma


subject: UMLS:C2346822

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: UMLS:C2346822


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024